ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1291

Semi-Quantitative and Quantitative Evaluation of Magnetic Resonance Imaging in Patients with Idiopathic Inflammatory Myopathies – a Subanalysis of the Prometheus Study

Katerina Kubinova1 and Jiří Vencovský 2, 1Institute of Rheumatology, Department of Rheumatology, 1st Faculty of Medicine, Prague, Czech Republic, Prague 2, 2Institute of Rheumatology, Department of Rheumatology, 1st Faculty of Medicine, Prague, Czech Republic, Prague 2, Czech Republic

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: magnetic resonance imaging (MRI) and evaluation, Myositis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 11, 2019

Title: Muscle Biology, Myositis & Myopathies Poster II

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Prometheus study was a prospective, randomized, assessor-blind multicenter trial, comparing the efficacy and safety of the glucocorticoid (GC) monotherapy versus combination therapy with methotrexate (MTX) and GC in patients with polymyositis (PM) and dermatomyositis (DM). Muscle MRI has been used to assess disease activity and response to treatment. To assess MRI findings two different methods were used: semi-quantitative scoring system and quantitative assessment using manual measuring tool and picture analysis provided by TomoCon® Workstation.

Methods: For semi-quantitative assessment of edema, we used scoring 0, 1, 2, and 3 according to intensity of signal in each of the 16 thigh muscles. Muscle damage was evaluated in three basic thigh muscle compartments and pelvic muscles using Goutallier grading (0 – 5) based on extent of fatty replacement. Both sides were assessed by two evaluators, an average was made for each muscle, and values were summed up in the total score (MRI Semi-Quantitative total edema score = MRI S-Q TES).  TomoCon® software provides pixel analysis in manually selected regions of interest. Manual muscle test (MMT8) and CK were measured and patient’s global assessment (PGA), physician’s GA (PhGA) and muscle disease activity (MDA) were recorded on visual analogue scales.

Results: Seventeen patients had MR images taken before the baseline visit, 8 had also the second MRI after 3 months of therapy. There was a significant reduction of MRI S-Q TES after 3 months in patients with PM and DM (from the mean 17.4 points, SD 13.7 to 8.0 points, SD 12.3; p=0.025). No significant progression of fatty atrophy was observed (from 16.0 points, SD 8.8, to 19.4, SD 4.6; p=0.3). At baseline, a significant correlation between MRI S-Q TES and PGA was noted (p=0.027). There was also a borderline negative association of MRI S-Q TES with muscle strength evaluated by MMT 8 (p=0.053). We noted a significant association between MRI S-Q TES and MRI Quantitative total edema score (MRI Q TES) (p=0.04) as well as between semi-quantitative and quantitative edema scores comparing individual muscles (p=0.0004). There was also a borderline association of MRI S-Q TES with MRI atrophy score (p=0.061). In a subset of 8 patients with longitudinally performed two MRI evaluations we found a good correlation between initial MRI S-Q TES and the level of serum CK (p=0.028).  However, no correlation was seen between the level of improvement in MRI S-Q TES and drop in CK or with any other clinical parameters after 3 months of treatment.

Conclusion: Compared to the results of established semi-quantitative scoring method we demonstrated a good reliability of newly proposed quantitative evaluation system of muscle edema. This system was applied to record degree of muscle edema in a subpopulation of patients with PM and DM, treated in the clinical study. A significant association between MRI S-Q TES and MRI Q TES was found. Correlations of MRI scores with clinical and laboratory parameters were demonstrated.

Acknowledgements: Supported by the project (Ministry of Health, Czech Republic) for conceptual development of research organization 00023728 (Institute of Rheumatology).


Disclosure: K. Kubinova, Ministry of Health, Czech Republic, project 00023728, 2; J. Vencovský, projeMinistry of Health, Czech Republic, project 00023728, 2.

To cite this abstract in AMA style:

Kubinova K, Vencovský J. Semi-Quantitative and Quantitative Evaluation of Magnetic Resonance Imaging in Patients with Idiopathic Inflammatory Myopathies – a Subanalysis of the Prometheus Study [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/semi-quantitative-and-quantitative-evaluation-of-magnetic-resonance-imaging-in-patients-with-idiopathic-inflammatory-myopathies-a-subanalysis-of-the-prometheus-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/semi-quantitative-and-quantitative-evaluation-of-magnetic-resonance-imaging-in-patients-with-idiopathic-inflammatory-myopathies-a-subanalysis-of-the-prometheus-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology